GlobeNewswire Inc.··NaDBV Technologies Reports 296M Shares Outstanding as Clinical Pipeline Advances
DBV Technologies reports 296M shares outstanding and 296M voting rights as of March 31, 2026, with updates on VIASKIN® Peanut Patch clinical programs.
DBVTfinancial resultsclinical development